FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti‐FLT3 interaction and flow cytometric method-Reference-Cited by-同舟云学术

FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti‐FLT3 interaction and flow cytometric method

Published:2019-02-08 Issue:4 Volume:33 Page:e22859
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Ampasavate Chadarat¹²^ORCID,Jutapakdee Wasimon¹,Phongpradist Rungsinee¹,Tima Singkome³,Tantiworawit Adisak⁴,Charoenkwan Pimlak⁵,Chinwong Dujrudee⁶,Anuchapreeda Songyot²³^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Faculty of Pharmacy Chiang Mai University Chiang Mai Thailand

2. Center for Research and Development of Natural Products for Health Chiang Mai University Chiang Mai Thailand

3. Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences Chiang Mai University Chiang Mai Thailand

4. Division of Hematology, Department of Internal Medicine, Faculty of Medicine Chiang Mai University Chiang Mai Thailand

5. Department of Pediatrics, Faculty of Medicine Chiang Mai University Chiang Mai Thailand

6. Department of Pharmaceutical Care, Faculty of Pharmacy Chiang Mai University Chiang Mai Thailand

Funder

Thailand Research Fund

Center for Research and Development of Natural Products for Health, Chiang Mai University

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.22859

Reference23 articles.

1. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm

2. FLT3: Receptor and Ligand. Biology and Potential Clinical Application

3. Expression of the hematopoietic growth factor receptor FLT3 (STK‐1/Flk2) in human leukemias;Carow CE;Blood,1996

4. The roles of FLT3 in hematopoiesis and leukemia

5. Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia;Stem Cell Reports;2024-01

2. Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2022-09-11

3. A Novel Predictive Model Incorporating Ferroptosis-Related Gene Signatures for Overall Survival in Patients with Lung Adenocarcinoma;Medical Science Monitor;2021-10-27

4. Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia;Cancer Chemotherapy and Pharmacology;2020-08-03

5. Erlotinib is effective against FLT3‐ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn;The FASEB Journal;2020-06-15